Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Commercial
Acquisitions
Acquisitions
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Acquisitions
AXIM Biotechnologies Acquiree Sapphire Biotech Signs Sponsored Research Agreement with Arizona State University to Develop Metastatic Cancer Inhibitor
Firstwordpharma News
-
February 10, 2020
Acquisitions
Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases
Acquisitions
CODA Biotherapeutics Acquires Attenua and Three Clinical Stage Assets
Acquisitions
Enochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potential Treatment or Cure
Acquisitions
WPD Pharmaceuticals Completed the Acquisition of Two Drug Candidates Bringing Total Development Funding Spent on Drugs Under License to Over USD $100 Million
Acquisitions
Sandoz Completes Acquisition of Aspen’s Japanese Operations
Biospace News
-
January 31, 2020
0
Acquisitions
Sorrento Therapeutics Rejects Acquisition Bid Worth Nearly $1 Billion
Biospace News
-
January 27, 2020
0
Acquisitions
Theramex Acquires Commercial Rights for Oral Contraceptive Zoely
Firstwordpharma News
-
January 22, 2020
0
Acquisitions
Coherus Acquires Commercial Rights for Avastin Biosimilar in the United States
Firstwordpharma News
-
January 13, 2020
0
Acquisitions
FTC Approves Final Order Requiring Bristol-Myers Squibb Company and Celgene Corporation...
Firstwordpharma News
-
January 13, 2020
0
1
2
3
...
23
Page 1 of 23
- Advertisement -
MOST POPULAR
People With Haemophilia and Female Carriers in Sweden Have Higher Risk...
July 8, 2019
Positive Phase II Data Further Highlights Clinical Proof of Concept for...
May 10, 2019
Sanofi Cuts the Costs of Some Insulin Products to $99 per...
April 10, 2019
Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diabetes...
December 3, 2019
Load more
HOT NEWS
Others
Patient Input and Clinical Experts: Vonvendi
Clinical
Contaminant Causes Mylan to Issue Recall for Single Lot of Alprazolam,...
Others
PLx Pharma Inc. Provides Regulatory Update on VAZALORE
Phase I
Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress...
